(株)Veritas In Silicoの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 130A/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/09/20 | 日証協 | 657,004株 | -0.93% | 20,400株 | -45.89% | 436,828株 | -0.36% | 8,408株 | -38.24% |
2024/09/13 | 日証協 | 663,204株 | +2.22% | 37,700株 | -75.83% | 438,420株 | +1.7% | 13,614株 | -77.27% |
2024/09/06 | 日証協 | 648,804株 | -1.73% | 156,000株 | +128.4% | 431,106株 | -2.69% | 59,901株 | +99.87% |
2024/08/30 | 日証協 | 660,200株 | +10.94% | 68,300株 | -73.57% | 443,005株 | +9.33% | 29,970株 | -72.59% |
2024/08/23 | 日証協 | 595,100株 | +2.67% | 258,400株 | +11.43% | 405,200株 | +0.84% | 109,330株 | +241.65% |
2024/08/16 | 日証協 | 579,600株 | -8.91% | 231,896株 | -31.65% | 401,835株 | -9.9% | 32,001株 | -67.24% |
2024/08/09 | 日証協 | 636,300株 | -9.91% | 339,292株 | +38.21% | 445,976株 | -2.81% | 97,696株 | +163.33% |
2024/08/02 | 日証協 | 706,285株 | -7.3% | 245,492株 | +12.51% | 458,876株 | -8.13% | 37,100株 | -5.62% |
2024/07/26 | 日証協 | 761,885株 | +14.21% | 218,192株 | +34.69% | 499,466株 | +10.56% | 39,310株 | -14% |
2024/07/19 | 日証協 | 667,085株 | -6.49% | 161,992株 | +146.2% | 451,766株 | -6.07% | 45,710株 | +111.52% |
2024/07/12 | 日証協 | 713,385株 | -1.27% | 65,796株 | -70.56% | 480,946株 | -0.76% | 21,610株 | -79.52% |
2024/07/05 | 日証協 | 722,585株 | +21.53% | 223,485株 | +295.55% | 484,646株 | +25.54% | 105,500株 | +258.84% |
2024/06/28 | 日証協 | 594,596株 | +1.28% | 56,500株 | +404.46% | 386,046株 | -2.35% | 29,400株 | +250% |
2024/06/21 | 日証協 | 587,096株 | -0.94% | 11,200株 | -72.21% | 395,346株 | -2.25% | 8,400株 | +21.74% |
2024/06/14 | 日証協 | 592,696株 | -1.71% | 40,296株 | -53.47% | 404,446株 | -2.86% | 6,900株 | -2.82% |
2024/06/07 | 日証協 | 602,996株 | -9.97% | 86,596株 | +236.95% | 416,346株 | -8% | 7,100株 | +18.33% |
2024/05/31 | 日証協 | 669,796株 | -0.74% | 25,700株 | -77.09% | 452,546株 | -1.76% | 6,000株 | -76.19% |
2024/05/24 | 日証協 | 674,796株 | +2.29% | 112,196株 | -20.65% | 460,646株 | +3.48% | 25,200株 | -19.3% |
2024/05/17 | 日証協 | 659,696株 | -0.39% | 141,396株 | -9.48% | 445,149株 | +0.43% | 31,226株 | -56.75% |
※株式分割は考慮していませんのでご注意ください。
Page Top